Search Results 481-490 of 14778 for anti-TNF drugs

  1. Anabolic Steroid (Oral Route, Parenteral Route) Side Effects - Mayo Clinic

    Tumors of the liver, liver cancer, or peliosis hepatis, a form of liver disease, have occurred during long-term, high-dose therapy with anabolic steroids.

  2. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Mayo Clinic

    Unstable biological therapy (e.g., TNF-α (anti-tumor necrosis factor), natalizumab, etc.), including significant changes in doses or switch of drug within 6 ...

  3. Flurbiprofen (Oral Route) Proper Use - Mayo Clinic

    This medicine comes with a Medication Guide. Read and follow the instructions carefully. Ask your doctor if you have any questions. Swallow the tablet whole. Do ...

  4. New treatment option for early type 1 diabetes - Mayo Clinic

    According to findings published in The New England Journal of Medicine in 2023, teplizumab is an anti-CD3 antibody approved for people 8 years and older ...

  5. Calcipotriene (Topical Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Calcitrene; Dovonex; Sorilux. Descriptions.

  6. Mayo Clinic expert talks benefits, risks of experimental Alzheimer's drug

    An experimental drug for Alzheimer's disease shows promise to slow the progression of the diseas. A Mayo Clinic Neurologist gives perspective.

  7. Mayo Clinic Comprehensive Cancer Center Research

    Research in the Experimental Therapeutics Program of Mayo Clinic Comprehensive Cancer Center focuses on signaling pathways, anti-cancer drugs, ...

  8. Tuberculin (Intradermal Route) Description and Brand Names - Mayo Clinic

    Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Aplisol; Tubersol. Descriptions. Tuberculin ...

  9. An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease - Mayo Clinic

    This is an investigational study, also known as LATTICE-CD, of the experimental medication BMS-986165 in participants with moderate to severe Crohn's Disease, a ...

  10. Mayo Clinic researchers identify cancer-fighting drugs that help morbidly obese mice to lose weight

    17 edition of Oncotarget. “We were surprised to observe that when morbidly obese mice were treated with certain cancer-fighting drugs, the drugs not only ...